title: Screening for natural chemoprevention agents that modify human Keap1.
abstract: Upregulation of cytoprotective enzymes by therapeutic agents to prevent damage by reactive oxygen species and xenobiotic electrophiles is a strategy for cancer chemoprevention. The Kelch-like ECH-associated protein 1 (Keap1) and its binding partner, transcription factor NF-E2-related factor-2 (NRF2), are chemoprevention targets because of their role in regulating the antioxidant response element (ARE) in response to oxidative stress and exposure to electrophiles. Modification of the sensor protein Keap1 by electrophiles such as the isothiocyanate sulforaphane can direct Nrf2 accumulation in the nucleus and subsequent ARE activation. Since our previous matrix-assisted laser desorption time-of-flight mass spectrometry (MALDI-TOF MS)-based screening method to discover natural products that modify Keap1 does not detect covalent modification of Keap1 by some highly reversible agents such as sulforaphane, a more sensitive screening assay was developed. In this new assay, electrophiles that have reversibly modified Keap1 can be released, trapped, and detected as β-mercaptoethanol adducts by mass spectrometry. Isoliquiritigenin and sulforaphane, known ARE activators that target Keap1, were used to validate the assay. To determine the ability of the assay to identify electrophiles in complex matrixes that modify Keap1, sulforaphane was spiked into a cocoa extract, and LC-MS/MS using high resolution mass spectrometry with accurate mass measurement was used to identify β-mercaptoethanol adducts of sulforaphane that had been released from Keap1. This screening assay permits identification of potential chemoprevention agents in complex natural product mixtures that reversibly modify Keap1 but cannot be detected using MALDI-TOF MS.
authors.affiliation: Department of Medicinal Chemistry and Pharmacognosy, University of Illinois College of Pharmacy, Chicago, IL 60612, USA.
authors.forename: Chenqi
authors.initials: C
authors.lastname: Hu
authors.forename: Dejan
authors.initials: D
authors.lastname: Nikolic
authors.forename: Aimee L
authors.initials: AL
authors.lastname: Eggler
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Mesecar
authors.forename: Richard B
authors.initials: RB
authors.lastname: van Breemen
mesh_terms: D016588:Anticarcinogenic Agents / Q000494:pharmacology*; D000975:Antioxidants / Q000494:pharmacology; D001688:Biological Products / Q000494:pharmacology; D002099:Cacao / Q000737:chemistry; D018890:Chemoprevention; D002853:Chromatography, Liquid; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D006801:Humans; D066298:In Vitro Techniques; D047908:Intracellular Signaling Peptides and Proteins / Q000737:chemistry* / Q000187:drug effects*; D000072019:Kelch-Like ECH-Associated Protein 1; D008623:Mercaptoethanol; D010936:Plant Extracts / Q000494:pharmacology; D011994:Recombinant Proteins / Q000737:chemistry / Q000187:drug effects; D021241:Spectrometry, Mass, Electrospray Ionization; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D053719:Tandem Mass Spectrometry
chemical_list: D016588:Anticarcinogenic Agents; D000975:Antioxidants; D001688:Biological Products; D047908:Intracellular Signaling Peptides and Proteins; C431364:KEAP1 protein, human; D000072019:Kelch-Like ECH-Associated Protein 1; D010936:Plant Extracts; D011994:Recombinant Proteins; D008623:Mercaptoethanol
references.citation: Toxicol Lett. 1995 Dec;82-83:173-9
references.pmid: 8597048
references.citation: Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):949-54
references.pmid: 11535546
references.citation: Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2040-5
references.pmid: 14764894
references.citation: Genes Dev. 1999 Jan 1;13(1):76-86
references.pmid: 9887101
references.citation: J Am Soc Mass Spectrom. 2007 Dec;18(12):2226-32
references.pmid: 17980616
references.citation: Mol Cell Biol. 2003 Nov;23(22):8137-51
references.pmid: 14585973
references.citation: J Nat Prod. 2006 Mar;69(3):460-3
references.pmid: 16562858
references.citation: Free Radic Biol Med. 2009 May 1;46(9):1250-9
references.pmid: 19353781
references.citation: Biochem J. 2009 Jul 29;422(1):171-80
references.pmid: 19489739
references.citation: J Agric Food Chem. 2009 Jul 8;57(13):5693-9
references.pmid: 19489609
references.citation: Anal Chem. 2005 Oct 1;77(19):6407-14
references.pmid: 16194107
references.citation: Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3147-50
references.pmid: 8159717
references.citation: Mol Cell Biol. 2009 Jan;29(2):493-502
references.pmid: 19001094
references.citation: Mol Cell Biol. 2004 Dec;24(24):10941-53
references.pmid: 15572695
references.citation: Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):847-51
references.pmid: 17416783
references.citation: Sci Signal. 2009 Sep 29;2(90):re7
references.pmid: 19797270
references.citation: Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11908-13
references.pmid: 12193649
references.citation: Carcinogenesis. 2010 Jan;31(1):90-9
references.pmid: 19793802
references.citation: Proc Natl Acad Sci U S A. 2005 Jul 19;102(29):10070-5
references.pmid: 16006525
references.citation: J Chem Inf Comput Sci. 1985 May;25(2):99-103
references.pmid: 4008538
references.citation: Phytochemistry. 2004 May;65(10):1317-30
references.pmid: 15231405
references.citation: Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10367-72
references.pmid: 9294217
references.citation: Free Radic Biol Med. 2007 Jun 1;42(11):1690-703
references.pmid: 17462537
references.citation: Proc Natl Acad Sci U S A. 2008 Oct 14;105(41):15926-31
references.pmid: 18838692
references.citation: Mol Pharmacol. 2006 Aug;70(2):493-500
references.pmid: 16675659
references.citation: Proc Natl Acad Sci U S A. 1988 Nov;85(21):8261-5
references.pmid: 3141925